p 112: combining granulocyte-colony stimulating factor (g-csf) and stem cells in treatment of traumatic brain injury (tbi)

Authors

ali mehri a. student research committee, faculty of medicine, mashhad university of medical sciences, mashhad, iran b. neuroscience department, mashhad university of medical sciences, mashhad, iran

mohammad moein vakilzadeh a. student research committee, faculty of medicine, mashhad university of medical sciences, mashhad, iran b. neuroscience department, mashhad university of medical sciences, mashhad, iran

amirhossein heidari a. student research committee, faculty of medicine, mashhad university of medical sciences, mashhad, iran b. neuroscience department, mashhad university of medical sciences, mashhad, iran

abstract

traumatic brain injury (tbi) is described as a situation in which the brain is damaged by an external force. it is considered to be a chief problem in health care. pharmacotherapy and stem cell therapy are the main treatments used in tbi. the purpose of these procedures is to control the inflammation in injured regions of brain. currently, there is no effective care for tbi that could regenerate neurons and rehabilitate the patients. according to recent studies, there are stem cells settled on different parts of cns that can play an important role in treatment of tbi. in stem cell therapy, we use the capacity of undifferentiated cells for healing the injured tissues. g-csf can broadly be defined as granulocyte-colony stimulating factor or colony-stimulating factor 3. it is a cytokine with the potential to suppress encephalitis, and control glutamate levels. studies that used stem cell therapy and g-csf administration in combination with each other, reported a significant increase of neurogenesis and a considerable decrease in neuron apoptosis, compared with when each of these procedures were used separately. however, few researches has been done in the field of combined therapies for tbi so far. hence, we believe further studies need to be performed to validate these results and evaluate the benefit of combined cytokine and stem cell therapies for tbi.

Upgrade to premium to download articles

Sign up to access the full text

Already have an account?login

similar resources

P 112: Combining Granulocyte-Colony Stimulating Factor (G-CSF) and Stem Cells in Treatment of Traumatic Brain Injury (TBI)

Traumatic brain injury (TBI) is described as a situation in which the brain is damaged by an external force. It is considered to be a chief problem in health care. Pharmacotherapy and stem cell therapy are the main treatments used in TBI. The purpose of these procedures is to control the inflammation in injured regions of brain. Currently, there is no effective care for TBI that could regenerat...

full text

Mobilization of stem cell with granulocyte-colony stimulating factor promotes recovery after traumatic brain injury in rat

Introduction: This study was designed to investigate the effects of granulocyte colony-stimulating factor (G-CSF) administration in rats for 6 weeks after traumatic brain injury (TBI). Methods: Adult male Wistar rats (n = 30) were injured with controlled cortical impact device and divided into four groups. The treatment groups (n = 10 each) were injected subcutaneously with recombinant human...

full text

Comparison of Transplantation of Bone Marrow Stromal Cells (BMSC) and Stem Cell Mobilization by Granulocyte Colony Stimulating Factor after Traumatic Brain Injury in Rat

Background: Recent clinical studies of treating traumatic brain injury (TBI) with autologous adult stem cells led us to compare effect of intravenous injection of bone marrow mesenchymal stem cells (BMSC) and bone marrow hematopoietic stem cell mobilization, induced by granulocyte colony stimulating factor (G-CSF), in rats with a cortical compact device. Methods: Forty adult male Wistar rats w...

full text

Combination of Stem Cell Mobilized by Granulocyte-Colony Stimulating Factor and Human Umbilical Cord Matrix Stem Cell: Therapy of Traumatic Brain Injury in Rats

Objective(s) Clinical studies of treating traumatic brain injury (TBI) with autologous adult stem cells led us to examine the impression of a combination therapy. This was performed by intravenous injection of human umbilical cord matrix stem cell (hUCMSC-Wharton,s jelly stem cell) with bone marrow cell mobilized by granulocytecolony stimulating factor (G-CSF) in rats injured with cortical com...

full text

Case Report: Combination Therapy with Mesenchymal Stem Cells and Granulocyte-Colony Stimulating Factor in a Case of Spinal Cord Injury

Introduction: Various neuroregenerative procedures have been recently employed along with neurorehabilitation programs to promote neurological function after Spinal Cord Injury (SCI), and recently most of them have focused on the acute stage of spinal cord injury. In this report, we present a case of acute SCI treated with neuroprotective treatments in conjunction with conventional reha...

full text

Granulocyte-colony stimulating factor (G-CSF) and granulocyte-macrophage colony stimulating factor (GM-CSF) for sepsis: a meta-analysis

INTRODUCTION To investigate the effects of G-CSF or GM-CSF therapy in non-neutropenic patients with sepsis. METHODS A systematic literature search of Medline, Embase and Cochrane Central Register of Controlled Trials was conducted using specific search terms. A manual review of references was also performed. Eligible studies were randomized control trials (RCTs) that compared granulocyte-colo...

full text

My Resources

Save resource for easier access later


Journal title:
مجله علوم اعصاب شفای خاتم

جلد ۵، شماره ۲، صفحات ۱۴۳-۱۴۳

Hosted on Doprax cloud platform doprax.com

copyright © 2015-2023